GLP-1 / GIP / Glucagon receptor agonist
Lyophilised 5 mg and 10 mg research vials. Reference: Jastreboff 2023 NEJM Phase 2 cohort, 48-week dose-finding study.
Catalogue entry ›Lyophilised GLP-1 / GIP / glucagon receptor-agonist research compounds for laboratory use across the United Arab Emirates. HPLC-verified, cold-chain courier, lot-level Certificate of Analysis. Same-day Dubai dispatch.
The GLP-1 receptor axis has become one of the most actively studied incretin-hormone pathways in modern endocrinology research. From the original GLP-1 mono-agonists (semaglutide, liraglutide) to dual GLP-1/GIP and triple GLP-1/GIP/glucagon receptor agonists, each generation has expanded the experimental toolkit for investigators studying glucose homeostasis, appetite regulation, hepatic lipid metabolism and adipose tissue remodelling.
The most recent triple receptor agonist published in the New England Journal of Medicine (Jastreboff et al., 2023) demonstrated dose-dependent body weight changes of −17% to −24% across a 48-week Phase 2 cohort, with significant improvements in cardiometabolic markers. These compounds are now in widespread use across academic and contract-research laboratories worldwide.
REVIVE LAB UAE supplies these compounds as lyophilised research vials to UAE-based investigators, biotech labs and contract-research organisations for in-vitro and biochemical assay use only.
Lyophilised 5 mg and 10 mg research vials. Reference: Jastreboff 2023 NEJM Phase 2 cohort, 48-week dose-finding study.
Catalogue entry ›Lyophilised 5 mg and 10 mg research vials. Reference: Stanley 2014 / Falutz 2007 lipodystrophy clinical research data.
Catalogue entry ›Lyophilised 5 mg research vials. Sikiric 2018 review of preclinical gastrointestinal and soft-tissue model data.
Catalogue entry ›Lyophilised 50 mg and 100 mg research vials. Reference: Pickart 2018 copper peptide review (collagen and follicle research models).
Catalogue entry ›0.9% benzyl alcohol bacteriostatic water for lyophilised peptide reconstitution. Required for in-vitro stability studies.
Catalogue entry ›Lyophilised 100 mg research vials. Reference: Trammell 2016 NAD+ metabolism research.
Catalogue entry ›Cold-chain delivery to Dubai, Abu Dhabi, Sharjah, Ajman, Al Ain, Ras Al Khaimah and Fujairah. Lot-level COA on every parcel.
Browse the catalogueEvery batch is independently HPLC-tested for purity and mass-spec validated for identity before release. The signed Certificate of Analysis ships with the outer parcel and is also emailed at dispatch confirmation. Cold-pack insulation protects each vial through the courier handoff — important during the summer months across the United Arab Emirates.
Same-day dispatch from the Dubai warehouse for orders placed before 3 PM Dubai time. Dubai, Abu Dhabi, Sharjah and Ajman arrive within 24 hours via the Emirates Post / Aramex express network. Al Ain, Ras Al Khaimah and Fujairah arrive within 24–48 hours via the Northern Emirates and East Coast routes. All seven emirates are covered with cash-on-delivery available at the door.
Investigators based in Dubai Marina, JBR, Business Bay, JVC, Jumeirah, DIFC, Palm Jumeirah, Downtown Dubai, Emirates Hills and Arabian Ranches typically receive same-day delivery windows.
In-vitro laboratory research, biochemical assay development, and protein-pathway characterisation by UAE-based academic, biotech and contract-research groups. Not for human or animal consumption.
Yes. Lot-level Certificate of Analysis ships printed on the outer carton and is emailed with the dispatch confirmation. HPLC purity floor is ≥98%, identity is mass-spec confirmed.
Same-day dispatch before 3 PM Dubai time. Dubai / Abu Dhabi / Sharjah / Ajman within 24 hours. Al Ain / RAK / Fujairah within 24–48 hours.
Yes — bank transfer, card, and cash-on-delivery to the courier at the door across the United Arab Emirates.
Same-day dispatch from Dubai. Lot COA included. Cold-chain courier across all seven emirates.
View the catalogue